ASPEN PHARMA TRADING LIMITED — China drug registrations and re-registration deadlines
11 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2027-12-15.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20181230 | ARIXTRA 磺达肝癸钠注射液 | 2028-06-15 | 2027-12-15 |
| 国药准字HJ20181135 | FRAXIPARINE 那屈肝素钙注射液 | 2028-06-28 | 2027-12-28 |
| 国药准字HJ20181136 | FRAXIPARINE 那屈肝素钙注射液 | 2028-06-28 | 2027-12-28 |
| 国药准字HJ20181137 | FRAXIPARINE 那屈肝素钙注射液 | 2028-06-28 | 2027-12-28 |
| 国药准字HJ20240027 | Fludrocortisone Acetate Tablets 醋酸氟氢可的松片 | 2029-05-20 | 2028-11-20 |
| 国药准字HJ20171273 | Diprivan 丙泊酚乳状注射液 | 2029-12-19 | 2029-06-19 |
| 国药准字HJ20171275 | Diprivan 丙泊酚乳状注射液 | 2029-12-19 | 2029-06-19 |
| 国药准字HJ20171277 | Diprivan 丙泊酚乳状注射液 | 2029-12-19 | 2029-06-19 |
| 国药准字HJ20171278 | Diprivan 丙泊酚乳状注射液 | 2029-12-19 | 2029-06-19 |
| 国药准字HJ20181155 | Mivacron 米库氯铵注射液 | 2030-01-05 | 2029-07-05 |
| 国药准字HJ20181156 | Mivacron 米库氯铵注射液 | 2030-01-05 | 2029-07-05 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.